CHRISTINA WANG: Open Payments
NPI 1861016362 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,417 in 195 payments from 21 companies in 2025. Trend: 2023 $3,844 · 2024 $7,035 · 2025 $14,417
Speaker / faculty: $8,400Food & beverage: $5,945Education: $72
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 20 | $8,153 |
| Lilly USA, LLC | 8 | $1,154 |
| ABBVIE INC. | 44 | $874 |
| GENZYME CORPORATION | 12 | $682 |
| UCB, Inc. | 17 | $501 |
| Amgen Inc. | 11 | $458 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $367 |
| Arcutis Biotherapeutics, Inc. | 5 | $335 |
| LEO Pharma Inc. | 14 | $271 |
| Incyte Corporation | 10 | $261 |
Products named: NEMLUVIO, DUPIXENT, EBGLYSS, Bimzelx, SKYRIZI, RINVOQ, Zoryve, Otezla.
Industry payments across CA — which companies pay providers there.
